Cerence (CRNC) Financials

$8.54 +0.05 (+0.59%)

Closing price 05/23/2025 04:00 PM Eastern

Extended Trading

$8.53 -0.01 (-0.12%)

As of 05/23/2025 07:23 PM Eastern

Annual Income Statements for Cerence

This table shows Cerence's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	9/30/2024	9/30/2023	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	-588	-56	-311
Consolidated Net Income / (Loss)	-588	-56	-311
Net Income / (Loss) Continuing Operations	-588	-56	-311
Total Pre-Tax Income	-585	-36	-199
Total Operating Income	-580	-27	-184
Total Gross Profit	244	199	231
Total Revenue	332	294	328
Operating Revenue	332	294	328
Total Cost of Revenue	87	95	97
Operating Cost of Revenue	87	95	97
Total Operating Expenses	824	227	415
Selling, General & Admin Expense	52	58	43
Marketing Expense	22	28	31
Research & Development Expense	122	123	107
Amortization Expense	2.20	5.85	12
Impairment Charge	609	0.00	214
Restructuring Charge	17	12	8.97
Total Other Income / (Expense), net	-4.67	-9.19	-14
Interest Expense	13	15	14
Interest & Investment Income	5.35	4.47	1.01
Other Income / (Expense), net	2.53	1.11	-1.02
Income Tax Expense	3.47	20	112
Basic Earnings per Share	($14.12)	($1.40)	($7.93)
Weighted Average Basic Shares Outstanding	41.64M	40.22M	39.19M
Diluted Earnings per Share	($14.12)	($1.40)	($7.93)
Weighted Average Diluted Shares Outstanding	41.64M	40.22M	39.19M
Weighted Average Basic & Diluted Shares Outstanding	42.83M	41.14M	39.94M

This table shows Cerence's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022	6/30/2022
Net Income / (Loss) Attributable to Common Shareholders	-24	-20	-314	-278	24	-12	-16	-26	-2.16	-230	-99
Consolidated Net Income / (Loss)	-24	-20	-314	-278	24	-12	-16	-26	-2.16	-230	-99
Net Income / (Loss) Continuing Operations	-24	-20	-314	-278	24	-12	-16	-26	-2.16	-230	-99
Total Pre-Tax Income	-19	-20	-356	-266	58	0.35	-13	-22	-0.91	-233	12
Total Operating Income	-17	-19	-355	-264	59	3.90	-8.50	-21	-1.98	-229	16
Total Gross Profit	33	35	50	47	112	58	41	43	57	34	65
Total Revenue	51	55	71	68	138	81	62	68	84	58	89
Operating Revenue	51	55	71	68	138	81	62	68	84	58	89
Total Cost of Revenue	18	20	20	21	26	23	21	25	26	24	24
Operating Cost of Revenue	18	20	20	21	26	23	21	25	26	24	24
Total Operating Expenses	50	54	405	311	53	54	49	64	59	263	49
Selling, General & Admin Expense	13	13	9.83	17	13	11	13	19	14	11	11
Marketing Expense	4.77	4.83	5.21	5.62	6.07	5.85	4.28	8.22	9.16	8.61	8.30
Research & Development Expense	21	25	31	32	33	35	30	28	29	25	26
Amortization Expense	0.55	0.55	0.55	0.56	0.55	0.56	0.55	2.39	2.35	-	2.86
Restructuring Charge	11	10	1.49	4.55	0.71	0.84	1.17	5.71	4.19	2.38	1.20
Total Other Income / (Expense), net	-1.68	-1.16	-1.19	-1.95	-0.38	-3.55	-4.94	-1.77	1.07	-3.46	-4.05
Interest Expense	3.39	3.10	3.10	3.11	3.24	3.13	4.12	4.00	3.51	3.79	3.82
Interest & Investment Income	1.44	1.44	1.29	1.19	1.43	1.23	1.21	1.16	0.87	0.59	0.24
Other Income / (Expense), net	0.27	0.50	0.63	-0.03	1.42	-1.65	-2.03	1.07	3.71	-0.26	-0.48
Income Tax Expense	5.67	0.03	-43	12	34	12	3.01	3.71	1.25	-2.66	111
Basic Earnings per Share	($0.57)	($0.54)	($7.50)	($6.66)	$0.58	($0.29)	($0.41)	($0.65)	($0.05)	($5.88)	($2.53)
Weighted Average Basic Shares Outstanding	42.90M	41.64M	41.80M	41.72M	41.19M	40.22M	40.32M	40.22M	39.96M	39.19M	39.31M
Diluted Earnings per Share	($0.57)	($0.49)	($7.50)	($6.66)	$0.53	($0.29)	($0.41)	($0.65)	($0.05)	($5.86)	($2.53)
Weighted Average Diluted Shares Outstanding	42.90M	41.64M	41.80M	41.72M	49.26M	40.22M	40.32M	40.22M	39.96M	39.19M	39.31M
Weighted Average Basic & Diluted Shares Outstanding	43.20M	42.83M	41.80M	41.78M	41.67M	41.14M	40.33M	40.31M	40.23M	39.94M	39.38M

This table details how cash moves in and out of Cerence's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	9/30/2024	9/30/2023	9/30/2022
Net Change in Cash & Equivalents	20	6.31	-34
Net Cash From Operating Activities	17	7.50	-2.14
Net Cash From Continuing Operating Activities	17	7.50	-2.14
Net Income / (Loss) Continuing Operations	-588	-56	-311
Consolidated Net Income / (Loss)	-588	-56	-311
Depreciation Expense	11	16	24
Non-Cash Adjustments To Reconcile Net Income	641	45	252
Changes in Operating Assets and Liabilities, net	-46	2.47	32
Net Cash From Investing Activities	4.38	5.82	-11
Net Cash From Continuing Investing Activities	4.38	5.82	-11
Purchase of Property, Plant & Equipment	-5.00	-5.12	-17
Purchase of Investments	0.00	-18	-32
Sale and/or Maturity of Investments	11	30	37
Other Investing Activities, net	-1.74	-1.36	2.02
Net Cash From Financing Activities	0.23	-5.33	-20
Net Cash From Continuing Financing Activities	0.23	-5.33	-20
Repayment of Debt	-0.42	-240	-6.25
Repurchase of Common Equity	-9.87	-4.89	-49
Issuance of Debt	0.00	235	0.00
Issuance of Common Equity	11	5.63	36
Other Financing Activities, net	-0.39	-0.45	-0.42
Effect of Exchange Rate Changes	-1.47	-1.68	-1.27
Cash Interest Paid	6.03	12	9.09
Cash Income Taxes Paid	10	11	12

This table details how cash moves in and out of Cerence's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022	6/30/2022
Net Change in Cash & Equivalents	-17	5.96	16	0.44	-2.42	15	-9.28	4.72	-4.19	-14	-3.37
Net Cash From Operating Activities	9.25	6.12	13	1.04	-2.82	11	-8.20	6.56	-2.12	-4.95	-3.93
Net Cash From Continuing Operating Activities	9.25	6.12	13	1.04	-2.82	11	-8.20	6.56	-2.12	-4.95	-3.93
Net Income / (Loss) Continuing Operations	-24	-20	-314	-278	24	-12	-16	-26	-2.16	-230	-99
Consolidated Net Income / (Loss)	-24	-20	-314	-278	24	-12	-16	-26	-2.16	-230	-99
Depreciation Expense	2.45	2.58	2.67	2.70	2.69	2.89	3.12	5.03	5.01	5.09	5.28
Non-Cash Adjustments To Reconcile Net Income	12	3.92	363	266	7.84	12	9.87	16	6.83	221	10
Changes in Operating Assets and Liabilities, net	20	20	-39	10	-37	7.45	-4.73	12	-12	-0.92	80
Net Cash From Investing Activities	0.76	0.05	4.08	-0.94	1.19	8.27	-4.67	0.71	1.52	-7.15	2.55
Net Cash From Continuing Investing Activities	0.76	0.05	4.08	-0.94	1.19	8.27	-4.67	0.71	1.52	-7.15	2.55
Purchase of Property, Plant & Equipment	-1.36	-1.45	-0.77	-1.85	-0.93	-1.53	-1.52	-1.39	-0.68	-3.03	-4.43
Sale and/or Maturity of Investments	2.49	1.91	5.30	1.47	2.44	10	4.30	6.40	9.50	6.20	15
Other Investing Activities, net	-0.37	-0.41	-0.44	-0.57	-0.32	-0.33	-0.47	-0.33	-0.22	0.28	0.47
Net Cash From Financing Activities	-27	0.17	-0.46	0.65	-0.13	-4.31	4.42	-2.39	-3.05	-1.61	-1.66
Net Cash From Continuing Financing Activities	-27	0.17	-0.46	0.65	-0.13	-4.31	4.42	-2.39	-3.05	-1.61	-1.66
Repayment of Debt	-27	-	-0.42	-	0.00	-25	-210	-3.13	-1.97	-1.56	-1.56
Repurchase of Common Equity	-1.37	-0.01	-0.11	-3.54	-6.21	-0.06	-0.40	-1.79	-2.64	-1.04	-1.54
Issuance of Common Equity	1.36	0.26	0.18	4.26	6.20	0.94	0.29	2.67	1.72	1.12	1.48
Other Financing Activities, net	-0.12	-0.09	-0.10	-0.08	-0.12	-0.10	-0.04	-0.15	-0.17	-0.13	-0.04
Effect of Exchange Rate Changes	-0.31	-0.37	-0.13	-0.31	-0.66	-0.16	-0.83	-0.15	-0.54	0.11	-0.33
Cash Interest Paid	3.08	1.64	1.31	0.07	3.00	0.10	4.98	2.15	4.34	1.36	3.57
Cash Income Taxes Paid	0.01	2.13	1.79	3.15	3.10	5.43	1.70	1.59	2.46	2.41	3.27

This table presents Cerence's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	9/30/2024	9/30/2023	9/30/2022
Total Assets	702	1,298	1,318
Total Current Assets	266	226	228
Cash & Equivalents	121	101	95
Short-Term Investments	5.50	9.21	20
Accounts Receivable	63	61	45
Prepaid Expenses	70	47	60
Other Current Assets	5.29	6.94	7.10
Plant, Property, & Equipment, net	30	34	38
Total Noncurrent Assets	407	1,038	1,053
Long-Term Investments	3.45	11	12
Goodwill	297	900	891
Intangible Assets	1.71	3.88	9.70
Noncurrent Deferred & Refundable Income Taxes	51	47	52
Other Noncurrent Operating Assets	53	76	89
Total Liabilities & Shareholders' Equity	702	1,298	1,318
Total Liabilities	561	603	606
Total Current Liabilities	217	148	147
Short-Term Debt	87	0.00	11
Accounts Payable	3.96	17	10
Accrued Expenses	68	49	48
Current Deferred Revenue	53	77	73
Other Current Liabilities	4.53	5.43	5.07
Total Noncurrent Liabilities	344	455	459
Long-Term Debt	195	276	259
Noncurrent Deferred Revenue	114	146	166
Other Noncurrent Operating Liabilities	35	33	33
Commitments & Contingencies	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	141	695	713
Total Preferred & Common Equity	141	695	713
Total Common Equity	141	695	713
Common Stock	1,089	1,057	1,030
Retained Earnings	-922	-334	-283
Accumulated Other Comprehensive Income / (Loss)	-26	-28	-34

This table presents Cerence's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022
Period end date	12/31/2024	6/30/2024	3/31/2024	12/31/2023	6/30/2023	3/31/2023	12/31/2022	6/30/2022
Total Assets	618	674	987	1,265	1,312	1,335	1,348	1,577
Total Current Assets	200	240	233	228	219	232	242	255
Cash & Equivalents	104	116	99	99	86	95	91	108
Short-Term Investments	3.89	5.44	9.36	9.78	17	12	17	19
Accounts Receivable	48	73	67	59	57	61	66	63
Prepaid Expenses	40	40	52	56	52	56	61	58
Other Current Assets	4.74	5.56	5.30	5.57	7.59	7.71	7.78	7.42
Plant, Property, & Equipment, net	29	31	32	33	35	36	37	38
Total Noncurrent Assets	388	404	722	1,004	1,058	1,068	1,069	1,284
Long-Term Investments	2.55	5.34	6.71	7.76	13	16	13	8.78
Goodwill	289	292	651	906	905	904	902	1,115
Intangible Assets	1.06	2.18	2.75	3.37	4.64	5.30	7.71	13
Noncurrent Deferred & Refundable Income Taxes	46	50	7.06	17	52	54	54	50
Other Noncurrent Operating Assets	50	54	55	70	83	89	92	98
Total Liabilities & Shareholders' Equity	618	674	987	1,265	1,312	1,335	1,348	1,577
Total Liabilities	497	520	524	534	609	626	628	627
Total Current Liabilities	152	183	107	120	168	166	165	154
Short-Term Debt	60	87	0.00	0.00	25	13	13	9.38
Accounts Payable	7.61	10	16	19	16	19	19	15
Accrued Expenses	33	38	40	52	47	53	52	49
Current Deferred Revenue	48	44	45	43	75	76	76	75
Other Current Liabilities	3.83	4.65	5.19	5.68	5.51	6.00	5.76	5.49
Total Noncurrent Liabilities	345	337	417	414	441	460	463	472
Long-Term Debt	196	193	279	277	255	265	267	261
Noncurrent Deferred Revenue	113	109	103	101	153	160	162	174
Other Noncurrent Operating Liabilities	35	34	35	35	33	35	33	38
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	121	154	463	731	703	709	720	950
Total Preferred & Common Equity	121	154	463	731	703	709	720	950
Total Common Equity	121	154	463	731	703	709	720	950
Common Stock	1,097	1,084	1,078	1,064	1,050	1,038	1,024	1,024
Retained Earnings	-946	-901	-588	-310	-322	-306	-280	-53
Accumulated Other Comprehensive Income / (Loss)	-30	-29	-27	-23	-25	-23	-24	-21

This table displays calculated financial ratios and metrics derived from Cerence's official financial filings.

Metric	2024	2023	2022
Period end date	9/30/2024	9/30/2023	9/30/2022
Growth Metrics	-	-	-
Revenue Growth	12.57%	-10.19%	-15.31%
EBITDA Growth	-5,537.92%	93.77%	-275.81%
EBIT Growth	-2,113.06%	85.92%	-398.22%
NOPAT Growth	-2,032.20%	85.25%	-323.99%
Net Income Growth	-945.40%	81.90%	-777.28%
EPS Growth	-908.57%	82.35%	-777.78%
Operating Cash Flow Growth	129.34%	450.70%	-102.87%
Free Cash Flow Firm Growth	1,328.64%	-108.13%	2,428.98%
Invested Capital Growth	-65.57%	-0.78%	-24.67%
Revenue Q/Q Growth	-7.26%	8.32%	-10.86%
EBITDA Q/Q Growth	-3.90%	95.81%	-298.43%
EBIT Q/Q Growth	-3.77%	89.88%	-436.33%
NOPAT Q/Q Growth	-4.15%	89.56%	-32.25%
Net Income Q/Q Growth	-1.53%	79.53%	-327.50%
EPS Q/Q Growth	-1.44%	79.91%	-326.34%
Operating Cash Flow Q/Q Growth	-23.02%	186.06%	-108.18%
Free Cash Flow Firm Q/Q Growth	-10.01%	-134.16%	429.64%
Invested Capital Q/Q Growth	-5.10%	-1.89%	-21.02%
Profitability Metrics	-	-	-
Gross Margin	73.69%	67.68%	70.37%
EBITDA Margin	-170.97%	-3.41%	-49.23%
Operating Margin	-174.94%	-9.24%	-56.22%
EBIT Margin	-174.18%	-8.86%	-56.53%
Profit (Net Income) Margin	-177.40%	-19.10%	-94.80%
Tax Burden Percent	100.59%	154.59%	156.39%
Interest Burden Percent	101.25%	139.47%	107.22%
Effective Tax Rate	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-71.07%	-2.23%	-12.95%
ROIC Less NNEP Spread (ROIC-NNEP)	-189.93%	-27.16%	-159.09%
Return on Net Nonoperating Assets (RNNOA)	-69.62%	-5.76%	-22.68%
Return on Equity (ROE)	-140.69%	-7.99%	-35.63%
Cash Return on Invested Capital (CROIC)	26.49%	-1.44%	15.20%
Operating Return on Assets (OROA)	-57.74%	-1.99%	-12.26%
Return on Assets (ROA)	-58.81%	-4.30%	-20.56%
Return on Common Equity (ROCE)	-140.69%	-7.99%	-35.63%
Return on Equity Simple (ROE_SIMPLE)	-416.79%	-8.10%	-43.60%
Net Operating Profit after Tax (NOPAT)	-406	-19	-129
NOPAT Margin	-122.46%	-6.47%	-39.36%
Net Nonoperating Expense Percent (NNEP)	118.86%	24.93%	146.15%
Cost of Revenue to Revenue	26.31%	32.32%	29.63%
SG&A Expenses to Revenue	15.83%	19.66%	13.01%
R&D to Revenue	36.67%	41.88%	32.67%
Operating Expenses to Revenue	248.63%	76.92%	126.59%
Earnings before Interest and Taxes (EBIT)	-577	-26	-185
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-567	-10	-161
Valuation Ratios	-	-	-
Price to Book Value (P/BV)	0.93	1.18	0.87
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.40	2.79	1.89
Price to Earnings (P/E)	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.97	1.15	0.89
Enterprise Value to Revenue (EV/Rev)	0.85	3.32	2.33
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	16.47	130.24	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	1.87	0.00	5.04
Leverage & Solvency	-	-	-
Debt to Equity	2.00	0.40	0.38
Long-Term Debt to Equity	1.38	0.40	0.36
Financial Leverage	0.37	0.21	0.14
Leverage Ratio	2.39	1.86	1.73
Compound Leverage Factor	2.42	2.59	1.86
Debt to Total Capital	66.64%	28.42%	27.50%
Short-Term Debt to Total Capital	20.59%	0.00%	1.11%
Long-Term Debt to Total Capital	46.05%	28.42%	26.38%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%
Common Equity to Total Capital	33.36%	71.58%	72.50%
Debt to EBITDA	-0.50	-27.45	-1.67
Net Debt to EBITDA	-0.27	-15.42	-0.89
Long-Term Debt to EBITDA	-0.34	-27.45	-1.61
Debt to NOPAT	-0.69	-14.49	-2.10
Net Debt to NOPAT	-0.37	-8.14	-1.11
Long-Term Debt to NOPAT	-0.48	-14.49	-2.01
Altman Z-Score	-3.85	0.69	0.17
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-
Current Ratio	1.22	1.52	1.55
Quick Ratio	0.88	1.16	1.09
Cash Flow Metrics	-	-	-
Free Cash Flow to Firm (FCFF)	151	-12	151
Operating Cash Flow to CapEx	344.20%	146.33%	-12.26%
Free Cash Flow to Firm to Interest Expense	12.06	-0.83	10.52
Operating Cash Flow to Interest Expense	1.37	0.51	-0.15
Operating Cash Flow Less CapEx to Interest Expense	0.97	0.16	-1.36
Efficiency Ratios	-	-	-
Asset Turnover	0.33	0.23	0.22
Accounts Receivable Turnover	5.35	5.54	7.24
Inventory Turnover	0.00	0.00	0.00
Fixed Asset Turnover	10.34	8.21	9.48
Accounts Payable Turnover	8.37	6.99	8.83
Days Sales Outstanding (DSO)	68.28	65.91	50.45
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Payable Outstanding (DPO)	43.58	52.25	41.34
Cash Conversion Cycle (CCC)	24.70	13.66	9.11
Capital & Investment Metrics	-	-	-
Invested Capital	293	850	857
Invested Capital Turnover	0.58	0.35	0.33
Increase / (Decrease) in Invested Capital	-557	-6.72	-281
Enterprise Value (EV)	283	977	764
Market Capitalization	132	822	620
Book Value per Share	$3.38	$17.23	$18.10
Tangible Book Value per Share	($3.77)	($5.19)	($4.76)
Total Capital	423	971	983
Total Debt	282	276	270
Total Long-Term Debt	195	276	259
Net Debt	151	155	144
Capital Expenditures (CapEx)	5.00	5.12	17
Debt-free, Cash-free Net Working Capital (DFCFNWC)	8.81	-33	-24
Debt-free Net Working Capital (DFNWC)	136	78	91
Net Working Capital (NWC)	49	78	80
Net Nonoperating Expense (NNE)	182	37	182
Net Nonoperating Obligations (NNO)	151	155	144
Total Depreciation and Amortization (D&A)	11	16	24
Debt-free, Cash-free Net Working Capital to Revenue	2.66%	-11.12%	-7.24%
Debt-free Net Working Capital to Revenue	40.96%	26.36%	27.88%
Net Working Capital to Revenue	14.69%	26.36%	24.55%
Earnings Adjustments	-	-	-
Adjusted Basic Earnings per Share	($14.12)	($1.40)	($7.93)
Adjusted Weighted Average Basic Shares Outstanding	41.64M	40.22M	39.19M
Adjusted Diluted Earnings per Share	($14.12)	($1.40)	($7.93)
Adjusted Weighted Average Diluted Shares Outstanding	41.64M	40.22M	39.19M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	42.83M	41.14M	39.94M
Normalized Net Operating Profit after Tax (NOPAT)	32	-11	27
Normalized NOPAT Margin	9.78%	-3.63%	8.19%
Pre Tax Income Margin	-176.35%	-12.36%	-60.62%
Debt Service Ratios	-	-	-
EBIT to Interest Expense	-46.00	-1.77	-12.88
NOPAT to Interest Expense	-32.34	-1.29	-8.97
EBIT Less CapEx to Interest Expense	-46.40	-2.11	-14.09
NOPAT Less CapEx to Interest Expense	-32.74	-1.64	-10.18
Payout Ratios	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%
Augmented Payout Ratio	-1.68%	-8.70%	-15.77%

This table displays calculated financial ratios and metrics derived from Cerence's official financial filings.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022	6/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-63.21%	-32.14%	14.40%	-0.83%	65.36%	38.90%	-30.75%	-20.73%	-11.40%	-40.72%	-8.02%
EBITDA Growth	-122.68%	-414.45%	-4,643.21%	-1,702.66%	829.54%	102.29%	-136.02%	-215.13%	-77.44%	-1,328.54%	-8.34%
EBIT Growth	-127.77%	-933.33%	-3,264.15%	-1,252.96%	3,356.34%	100.98%	-168.83%	-412.89%	-92.35%	-2,208.45%	1.17%
NOPAT Growth	-149.36%	89.65%	-4,074.86%	-1,182.35%	1,835.21%	18.97%	95.54%	-1,333.40%	-106.13%	-1,500.91%	-1,927.72%
Net Income Growth	-201.81%	-76.73%	-1,805.46%	-965.49%	1,205.51%	94.98%	83.42%	-5,380.88%	-111.33%	-2,979.83%	-1,812.09%
EPS Growth	-207.55%	-68.97%	-1,729.27%	-924.62%	1,160.00%	95.05%	83.79%	-6,400.00%	-110.64%	-2,890.48%	-1,786.67%
Operating Cash Flow Growth	428.74%	-45.68%	256.79%	-84.07%	-32.91%	327.30%	-108.68%	310.20%	-141.17%	-121.24%	-116.33%
Free Cash Flow Firm Growth	5,385.23%	540.87%	45.71%	-82.89%	-96.10%	-202.82%	359.26%	800.59%	4,087.48%	398.72%	-65.16%
Invested Capital Growth	-70.15%	-65.57%	-64.41%	-27.42%	1.46%	-0.78%	-20.13%	-26.85%	-24.69%	-24.67%	-4.54%
Revenue Q/Q Growth	-7.13%	-22.31%	4.00%	-50.97%	71.28%	30.98%	-9.84%	-18.25%	43.88%	-34.70%	3.20%
EBITDA Q/Q Growth	11.94%	95.41%	-34.35%	-517.48%	1,121.04%	169.26%	48.94%	-315.27%	103.00%	-1,190.99%	63.19%
EBIT Q/Q Growth	11.02%	94.71%	-33.99%	-540.67%	2,570.32%	121.34%	46.11%	-1,225.75%	100.76%	-1,600.68%	144.94%
NOPAT Q/Q Growth	11.94%	94.58%	-34.24%	-870.68%	118.46%	-2,085.91%	58.77%	-942.84%	99.14%	-20.21%	-13,164.35%
Net Income Q/Q Growth	-18.97%	93.49%	-12.80%	-1,265.18%	306.52%	29.80%	36.93%	-1,108.94%	99.06%	-131.83%	-20,754.41%
EPS Q/Q Growth	-16.33%	93.47%	-12.61%	-1,356.60%	282.76%	29.27%	36.92%	-1,200.00%	99.15%	-131.62%	-25,200.00%
Operating Cash Flow Q/Q Growth	51.33%	-52.42%	1,131.03%	137.09%	-125.00%	237.34%	-225.05%	409.49%	57.24%	-26.09%	-345.81%
Free Cash Flow Firm Q/Q Growth	12.92%	75.71%	497.71%	362.51%	109.08%	-158.08%	-29.80%	5.48%	139.11%	246.44%	-89.69%
Invested Capital Q/Q Growth	-8.97%	-5.10%	-50.84%	-29.73%	4.99%	-1.89%	0.27%	-1.77%	2.67%	-21.02%	-8.16%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	64.98%	63.67%	71.50%	69.21%	80.96%	71.49%	66.04%	63.43%	68.70%	58.06%	72.76%
EBITDA Margin	-27.93%	-29.46%	-498.47%	-385.86%	45.32%	6.36%	-12.02%	-21.23%	8.06%	-386.12%	23.11%
Operating Margin	-33.27%	-35.08%	-503.13%	-389.80%	42.35%	4.82%	-13.79%	-30.14%	-2.36%	-394.42%	17.72%
EBIT Margin	-32.74%	-34.17%	-502.25%	-389.84%	43.37%	2.78%	-17.08%	-28.57%	2.08%	-394.86%	17.18%
Profit (Net Income) Margin	-47.72%	-37.25%	-444.50%	-409.84%	17.25%	-14.30%	-26.69%	-38.15%	-2.58%	-395.79%	-111.48%
Tax Burden Percent	130.46%	100.16%	88.05%	104.37%	40.99%	-3,338.73%	122.40%	116.56%	237.67%	98.86%	-846.48%
Interest Burden Percent	111.74%	108.85%	100.51%	100.73%	96.99%	15.40%	127.66%	114.53%	-52.30%	101.39%	76.65%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	59.01%	3,438.73%	0.00%	0.00%	0.00%	0.00%	946.48%
Return on Invested Capital (ROIC)	-9.81%	-14.25%	-214.39%	-127.59%	6.84%	-55.59%	-2.69%	-6.18%	-0.51%	-90.82%	-49.68%
ROIC Less NNEP Spread (ROIC-NNEP)	-17.92%	-18.79%	-255.40%	-186.00%	6.74%	23.80%	-9.74%	-14.53%	-1.07%	-146.77%	-22.12%
Return on Net Nonoperating Assets (RNNOA)	-6.45%	-6.89%	-94.61%	-50.45%	1.49%	5.05%	-1.76%	-2.30%	-0.17%	-20.92%	-2.79%
Return on Equity (ROE)	-16.26%	-21.14%	-309.00%	-178.04%	8.33%	-50.54%	-4.45%	-8.47%	-0.68%	-111.74%	-52.48%
Cash Return on Invested Capital (CROIC)	28.85%	26.49%	28.64%	12.01%	-6.46%	-1.44%	3.70%	14.84%	13.85%	15.20%	-4.14%
Operating Return on Assets (OROA)	-8.49%	-11.33%	-180.79%	-117.02%	11.59%	0.63%	-3.21%	-5.63%	0.43%	-85.62%	3.85%
Return on Assets (ROA)	-12.37%	-12.35%	-160.00%	-123.02%	4.61%	-3.22%	-5.02%	-7.51%	-0.54%	-85.82%	-24.96%
Return on Common Equity (ROCE)	-16.26%	-21.14%	-309.00%	-178.04%	8.33%	-50.54%	-4.45%	-8.47%	-0.68%	-111.74%	-52.48%
Return on Equity Simple (ROE_SIMPLE)	-527.10%	0.00%	-375.63%	-60.88%	-4.14%	0.00%	-39.10%	-50.41%	-46.12%	0.00%	-7.65%
Net Operating Profit after Tax (NOPAT)	-12	-13	-248	-185	24	-130	-5.95	-14	-1.38	-161	-134
NOPAT Margin	-23.29%	-24.56%	-352.19%	-272.86%	17.36%	-161.06%	-9.65%	-21.10%	-1.65%	-276.10%	-149.99%
Net Nonoperating Expense Percent (NNEP)	8.11%	4.54%	41.02%	58.41%	0.10%	-79.39%	7.05%	8.35%	0.56%	55.95%	-27.56%
Return On Investment Capital (ROIC_SIMPLE)	-3.15%	-	-	-	2.38%	-	-	-	-	-	-
Cost of Revenue to Revenue	35.02%	36.33%	28.50%	30.79%	19.04%	28.51%	33.96%	36.57%	31.30%	41.94%	27.24%
SG&A Expenses to Revenue	25.06%	24.06%	13.94%	24.56%	9.25%	14.18%	21.11%	28.04%	17.04%	18.42%	11.92%
R&D to Revenue	41.00%	46.03%	44.21%	46.95%	24.08%	43.51%	48.98%	41.66%	35.26%	43.53%	29.25%
Operating Expenses to Revenue	98.25%	98.76%	574.63%	459.01%	38.62%	66.66%	79.83%	93.57%	71.07%	452.49%	55.04%
Earnings before Interest and Taxes (EBIT)	-17	-19	-354	-264	60	2.25	-11	-20	1.74	-230	15
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-14	-16	-352	-262	63	5.13	-7.41	-15	6.74	-225	21
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.79	0.93	0.77	1.42	1.08	1.18	1.68	1.59	1.03	0.87	1.04
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	1.38	0.40	0.33	1.88	2.27	2.79	4.33	3.78	2.33	1.89	2.70
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	1.81	0.97	0.88	1.31	1.07	1.15	1.55	1.49	1.02	0.89	1.04
Enterprise Value to Revenue (EV/Rev)	1.97	0.85	0.76	2.35	2.73	3.32	4.94	4.29	2.84	2.33	3.06
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	20.79	0.00	0.00	0.00	0.00	0.00	13.84
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	29.65	0.00	0.00	0.00	0.00	0.00	20.43
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	16.46	16.47	12.19	635.68	140.29	130.24	0.00	0.00	0.00	0.00	43.09
Enterprise Value to Free Cash Flow (EV/FCFF)	2.88	1.87	1.62	9.16	0.00	0.00	37.21	8.47	6.35	5.04	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	2.12	2.00	1.82	0.60	0.38	0.40	0.40	0.39	0.39	0.38	0.28
Long-Term Debt to Equity	1.63	1.38	1.25	0.60	0.38	0.40	0.36	0.37	0.37	0.36	0.27
Financial Leverage	0.36	0.37	0.37	0.27	0.22	0.21	0.18	0.16	0.16	0.14	0.13
Leverage Ratio	2.21	2.39	2.32	1.98	1.80	1.86	1.75	1.72	1.72	1.73	1.67
Compound Leverage Factor	2.47	2.60	2.33	1.99	1.75	0.29	2.23	1.97	-0.90	1.76	1.28
Debt to Total Capital	67.97%	66.64%	64.52%	37.57%	27.51%	28.42%	28.45%	28.09%	27.99%	27.50%	22.17%
Short-Term Debt to Total Capital	15.91%	20.59%	20.01%	0.00%	0.00%	0.00%	2.51%	1.27%	1.25%	1.11%	0.77%
Long-Term Debt to Total Capital	52.06%	46.05%	44.51%	37.57%	27.51%	28.42%	25.93%	26.83%	26.74%	26.38%	21.40%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	32.03%	33.36%	35.48%	62.43%	72.49%	71.58%	71.55%	71.91%	72.01%	72.50%	77.83%
Debt to EBITDA	-0.40	-0.50	-0.51	-1.39	6.05	-27.45	-1.17	-1.31	-1.52	-1.67	3.33
Net Debt to EBITDA	-0.23	-0.27	-0.28	-0.81	3.51	-15.42	-0.68	-0.73	-0.86	-0.89	1.65
Long-Term Debt to EBITDA	-0.30	-0.34	-0.35	-1.39	6.05	-27.45	-1.06	-1.25	-1.45	-1.61	3.21
Debt to NOPAT	-0.56	-0.69	-0.72	-1.89	-6.25	-14.49	-1.53	-1.68	-1.91	-2.10	-2.77
Net Debt to NOPAT	-0.32	-0.37	-0.40	-1.11	-3.63	-8.14	-0.90	-0.93	-1.09	-1.11	-1.38
Long-Term Debt to NOPAT	-0.43	-0.48	-0.50	-1.89	-6.25	-14.49	-1.40	-1.60	-1.83	-2.01	-2.68
Altman Z-Score	-1.34	-1.23	-2.84	-0.46	1.08	0.76	1.04	1.00	0.72	0.06	1.24
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.32	1.22	1.31	2.18	1.90	1.52	1.30	1.40	1.47	1.55	1.65
Quick Ratio	1.02	0.88	1.06	1.64	1.39	1.16	0.95	1.02	1.05	1.09	1.23
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	614	544	309	52	11	-123	212	303	287	120	-82
Operating Cash Flow to CapEx	680.44%	422.89%	1,660.47%	56.59%	-302.36%	737.26%	-539.28%	470.23%	-310.10%	-163.57%	-88.61%
Free Cash Flow to Firm to Interest Expense	180.99	175.32	99.71	16.64	3.46	-39.39	51.55	75.59	81.64	31.64	-21.48
Operating Cash Flow to Interest Expense	2.73	1.97	4.14	0.34	-0.87	3.59	-1.99	1.64	-0.60	-1.31	-1.03
Operating Cash Flow Less CapEx to Interest Expense	2.33	1.51	3.89	-0.26	-1.16	3.11	-2.36	1.29	-0.80	-2.10	-2.19
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.26	0.33	0.36	0.30	0.27	0.23	0.19	0.20	0.21	0.22	0.22
Accounts Receivable Turnover	4.59	5.35	5.51	5.44	5.58	5.54	4.54	5.47	6.09	7.24	6.35
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	7.87	10.34	10.89	10.27	10.04	8.21	7.45	8.22	8.89	9.48	10.70
Accounts Payable Turnover	5.88	8.37	6.84	5.15	4.98	6.99	6.13	5.37	7.23	8.83	7.30
Days Sales Outstanding (DSO)	79.53	68.28	66.26	67.14	65.41	65.91	80.34	66.77	59.97	50.45	57.48
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	62.10	43.58	53.37	70.89	73.30	52.25	59.54	67.93	50.49	41.34	50.01
Cash Conversion Cycle (CCC)	17.43	24.70	12.89	-3.76	-7.89	13.66	20.81	-1.16	9.47	9.11	7.46
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	266	293	308	627	892	850	866	864	879	857	1,085
Invested Capital Turnover	0.42	0.58	0.61	0.47	0.39	0.35	0.28	0.29	0.31	0.33	0.33
Increase / (Decrease) in Invested Capital	-626	-557	-558	-237	13	-6.72	-218	-317	-288	-281	-52
Enterprise Value (EV)	482	283	272	820	954	977	1,342	1,284	900	764	1,126
Market Capitalization	336	132	118	656	793	822	1,178	1,130	740	620	992
Book Value per Share	$2.82	$3.38	$3.69	$11.12	$17.75	$17.23	$17.44	$17.64	$18.02	$18.10	$24.17
Tangible Book Value per Share	($3.95)	($3.77)	($3.36)	($4.56)	($4.34)	($5.19)	($5.13)	($4.97)	($4.75)	($4.76)	($4.50)
Total Capital	377	423	435	742	1,009	971	982	987	1,000	983	1,221
Total Debt	256	282	280	279	277	276	279	277	280	270	271
Total Long-Term Debt	196	195	193	279	277	276	255	265	267	259	261
Net Debt	146	151	154	164	161	155	163	154	160	144	134
Capital Expenditures (CapEx)	1.36	1.45	0.77	1.85	0.93	1.53	1.52	1.39	0.68	3.03	4.43
Debt-free, Cash-free Net Working Capital (DFCFNWC)	0.05	8.81	22	18	-0.14	-33	-27	-29	-18	-24	-17
Debt-free Net Working Capital (DFNWC)	108	136	143	126	108	78	75	78	89	91	110
Net Working Capital (NWC)	48	49	56	126	108	78	51	66	77	80	101
Net Nonoperating Expense (NNE)	12	6.96	65	93	0.16	-119	11	12	0.77	70	-34
Net Nonoperating Obligations (NNO)	146	151	154	164	161	155	163	154	160	144	134
Total Depreciation and Amortization (D&A)	2.45	2.58	2.67	2.70	2.69	2.89	3.12	5.03	5.01	5.09	5.28
Debt-free, Cash-free Net Working Capital to Revenue	0.02%	2.66%	6.24%	5.04%	-0.04%	-11.12%	-10.08%	-9.57%	-5.59%	-7.24%	-4.68%
Debt-free Net Working Capital to Revenue	44.27%	40.96%	40.08%	36.17%	31.04%	26.36%	27.74%	26.20%	28.20%	27.88%	29.94%
Net Working Capital to Revenue	19.70%	14.69%	15.75%	36.17%	31.04%	26.36%	18.65%	22.02%	24.26%	24.55%	27.40%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.57)	($0.54)	($7.50)	($6.66)	$0.58	($0.29)	($0.41)	($0.65)	($0.05)	($5.88)	($2.53)
Adjusted Weighted Average Basic Shares Outstanding	42.90M	41.64M	41.80M	41.72M	41.19M	40.22M	40.32M	40.22M	39.96M	39.19M	39.31M
Adjusted Diluted Earnings per Share	($0.57)	($0.49)	($7.50)	($6.66)	$0.53	($0.29)	($0.41)	($0.65)	($0.05)	($5.86)	($2.53)
Adjusted Weighted Average Diluted Shares Outstanding	42.90M	41.64M	41.80M	41.72M	49.26M	40.22M	40.32M	40.22M	39.96M	39.19M	39.31M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	($0.05)	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	43.20M	42.83M	41.80M	41.78M	41.67M	41.14M	40.33M	40.31M	40.23M	39.94M	39.38M
Normalized Net Operating Profit after Tax (NOPAT)	-4.11	-6.23	2.56	-5.42	41	3.32	-5.13	-10	1.55	-159	12
Normalized NOPAT Margin	-8.07%	-11.36%	3.63%	-7.98%	30.00%	4.11%	-8.32%	-15.25%	1.85%	-273.23%	13.34%
Pre Tax Income Margin	-36.58%	-37.19%	-504.82%	-392.67%	42.07%	0.43%	-21.80%	-32.73%	-1.09%	-400.37%	13.17%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-4.91	-6.04	-114.14	-84.99	18.54	0.72	-2.56	-4.88	0.49	-60.55	4.01
NOPAT to Interest Expense	-3.49	-4.34	-80.04	-59.49	7.42	-41.53	-1.44	-3.61	-0.39	-42.33	-35.01
EBIT Less CapEx to Interest Expense	-5.31	-6.50	-114.39	-85.58	18.25	0.23	-2.93	-5.23	0.30	-61.34	2.85
NOPAT Less CapEx to Interest Expense	-3.89	-4.81	-80.29	-60.08	7.13	-42.02	-1.81	-3.95	-0.59	-43.13	-36.17
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	-0.79%	-1.68%	-1.71%	-3.62%	-27.98%	-8.70%	-2.14%	-1.96%	-2.13%	-15.77%	-82.03%

Frequently Asked Questions About Cerence's Financials

When does Cerence's financial year end?

According to the most recent income statement we have on file, Cerence's fiscal year ends in September. Their fiscal year 2024 ended on September 30, 2024.

How has Cerence's net income changed over the last 2 years?

Cerence's net income appears to be on an upward trend, with a most recent value of -$588.08 million in 2024, rising from -$310.83 million in 2022. The previous period was -$56.25 million in 2023. Check out Cerence's forecast to explore projected trends and price targets.

What is Cerence's operating income?

Cerence's total operating income in 2024 was -$579.94 million, based on the following breakdown:

Total Gross Profit: $244.27 million
Total Operating Expenses: $824.21 million

How has Cerence revenue changed over the last 2 years?

Over the last 2 years, Cerence's total revenue changed from $327.89 million in 2022 to $331.50 million in 2024, a change of 1.1%.

How much debt does Cerence have?

Cerence's total liabilities were at $561.26 million at the end of 2024, a 6.9% decrease from 2023, and a 7.3% decrease since 2022.

How much cash does Cerence have?

In the past 2 years, Cerence's cash and equivalents has ranged from $94.85 million in 2022 to $121.49 million in 2024, and is currently $121.49 million as of their latest financial filing in 2024.

How has Cerence's book value per share changed over the last 2 years?

Over the last 2 years, Cerence's book value per share changed from 18.10 in 2022 to 3.38 in 2024, a change of -81.4%.

Related Companies

This page (NASDAQ:CRNC) was last updated on 5/24/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Cerence (CRNC) Financials

Frequently Asked Questions About Cerence's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Cerence (CRNC) Financials

Annual Income Statements for Cerence

Quarterly Income Statements for Cerence

Annual Cash Flow Statements for Cerence

Quarterly Cash Flow Statements for Cerence

Annual Balance Sheets for Cerence

Quarterly Balance Sheets for Cerence

Annual Metrics And Ratios for Cerence

Quarterly Metrics And Ratios for Cerence

Frequently Asked Questions About Cerence's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools